• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human UBL4A Polyclonal Antibody

The antibody against UBL4A was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-157 of human UBL4A (NP_055050.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IP, ELISA.

ADA-03993A

The antibody against UBL4A was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 1-157 of human UBL4A (NP_055050.1) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, IP, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-03993A ClonalityPolyclonal
Host SpeciesRabbitTarget NameUBL4A
Target SynonymsGDX; G6PD; GET5; MDY2; UBL4; TMA24; DX254E; DXS254E; UBL4AFormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesHeLa, Mouse kidney, A-549, Mouse brain, U-87MGApplicationELISA, WB, IP

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 1-157 of human UBL4A (NP_055050.1).Target SpeciesHuman
Immunogen SequenceMQLTVKALQGRECSLQVPEDELVSTLKQLVSEKLNVPVRQQRLLFKGKALADGKRLSDYSIGPNSKLNLVVKPLEKVLLEEGEAQRLADSPPPQVWQLISKVLARHFSAADASRVLEQLQRDYERSLSRLTLDDIERLASRFLHPEVTETMEKGFSKUniprot IDP11441
Background Information
  • Uniprot Id

    P11441

  • Target Species

    Human

  • Target Name

    UBL4A

  • Target Full Name

    Ubiquitin-like protein 4A

  • Target Function

    As part of a cytosolic protein quality control complex, the BAG6/BAT3 complex, maintains misfolded and hydrophobic patches-containing proteins in a soluble state and participates in their proper delivery to the endoplasmic reticulum or alternatively can promote their sorting to the proteasome where they undergo degradation. The BAG6/BAT3 complex is involved in the post-translational delivery of tail-anchored/type II transmembrane proteins to the endoplasmic reticulum membrane. Recruited to ribosomes, it interacts with the transmembrane region of newly synthesized tail-anchored proteins and together with SGTA and ASNA1 mediates their delivery to the endoplasmic reticulum. Client proteins that cannot be properly delivered to the endoplasmic reticulum are ubiquitinated and sorted to the proteasome. Similarly, the BAG6/BAT3 complex also functions as a sorting platform for proteins of the secretory pathway that are mislocalized to the cytosol either delivering them to the proteasome for degradation or to the endoplasmic reticulum. The BAG6/BAT3 complex also plays a role in the endoplasmic reticulum-associated degradation (ERAD), a quality control mechanism that eliminates unwanted proteins of the endoplasmic reticulum through their retrotranslocation to the cytosol and their targeting to the proteasome. It maintains these retrotranslocated proteins in an unfolded yet soluble state condition in the cytosol to ensure their proper delivery to the proteasome.

  • Target Subcellular Location

    Cytoplasm, cytosol. Nucleus.

  • Target Synonyms

    DX254E; DXS254E; G6PD; GDX; OTTHUMP00000061462; Ubiquitin like 4; Ubiquitin like 4A; Ubiquitin like protein 4A; Ubiquitin like protein GDX; Ubiquitin-like protein 4A; Ubiquitin-like protein GDX; UBL 4; UBL 4A; UBL4; Ubl4a; UBL4A_HUMAN

  • Target Background

    Enables chaperone binding activity. Involved in tail-anchored membrane protein insertion into ER membrane. Located in cytosol; membrane; and nucleoplasm. Part of BAT3 complex.

Inquire Rabbit anti-Human UBL4A Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification